Abound Wealth Management Dexcom Inc Transaction History
Abound Wealth Management
- $312 Billion
- Q4 2024
A detailed history of Abound Wealth Management transactions in Dexcom Inc stock. As of the latest transaction made, Abound Wealth Management holds 51 shares of DXCM stock, worth $3,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 53
3.77%
Holding current value
$3,482
Previous $3.55 Million
11.62%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DXCM
# of Institutions
1,084Shares Held
352MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.18 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.36 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.14 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$998 Million0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$981 Million0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...